The AI gold rush is in full swing. With 85% of enterprises now actively pursuing AI initiatives and 92% of executives planning to increase AI spending, the question has shifted from “if” to “how effectively.” Global AI spending is projected to reach $630 billion by 2028, and organizations are betting big on transformation.

Credit unions have always occupied a distinct place in the U.S. financial system. Member-owned and community-rooted, they now serve more than 140 million Americans and steward over $2.3 trillion in assets. That trust has been earned over decades, and it remains their greatest advantage.

Attending the 20th Clinical Trials Strategic Summit (CTSS) in San Francisco this October was both energizing and reaffirming. The conversations, the curiosity, and the shared drive for transformation reminded me why collaboration in clinical research has never been more critical.

When I attended the Drug Discovery Strategic Summit (DDSS) in San Francisco this October, I could sense a shift in the industry’s mindset. Conversations were focused, practical, and centered on impact. From digital diagnostics startups and device makers to pharma leaders shaping digital strategy, everyone shared one goal: making data truly drive discovery.